logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ASH 2019 – Peripheral T-cell lymphoma: nivolumab shows modest activity

Studies targeting this pathway with anti-programmed cell death protein 1/nivolumab are limited.